RCUS
Arcus Biosciences Inc.
$22.05
+$0.82(+3.86%)
80
Overall
60
Value
100
Tech
--
Quality
Market Cap
$2.18B
Volume
2.03M
52W Range
$6.50 - $22.11
Target Price
$32.36
Company Overview
| Mkt Cap | $2.18B | Price | $22.05 |
| Volume | 2.03M | Change | +3.86% |
| P/E Ratio | -7.7 | Open | $21.19 |
| Revenue | $258.0M | Prev Close | $21.23 |
| Net Income | $-283.0M | 52W Range | $6.50 - $22.11 |
| Div Yield | N/A | Target | $32.36 |
| Overall | 80 | Value | 60 |
| Quality | -- | Technical | 100 |
No chart data available
Latest News
Analysts Offer Insights on Healthcare Companies: MiMedx Group (MDXG), TransMedics Group (TMDX) and Arcus Biosciences (RCUS)
Catie Powers•24 days ago
Wedbush Reaffirms Their Buy Rating on Arcus Biosciences (RCUS)
TipRanks Auto-Generated Intelligence Newsdesk•24 days ago
Arcus Biosciences Reports Promising Q3 2025 Results
TipRanks Auto-Generated Newsdesk•25 days ago
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | RCUS | $22.05 | +3.9% | 2.03M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |